Chitosan-protein scaffolds loaded with lysostaphin as potential antistaphylococcal wound dressing materials

Journal of Applied Microbiology

Volumn 117, Issue 3, 2014, Pages 634-642

  Szweda, P ^a   Gorczyca, G ^a   Tylingo, R ^a   Kurlenda, J ^b   Kwiecinski, J ^c   Milewski, S ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^b State Higher Vocational School in Koszalin   (Poland)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Carbon dioxide; Chitosan; Collagen; Lysostaphin; Wound dressing

Indexed keywords

BACTERIA; BACTERICIDES; CARBON DIOXIDE; COLLAGEN; SCAFFOLDS (BIOLOGY);

BACTERICIDAL ACTIVITY; LARGE N; LYSOSTAPHIN; PROTEIN SCAFFOLDS; SKIN INFECTION; SOFT TISSUE INFECTIONS; SOLUBILISATION; STAPHYLOCOCCUS AUREUS; WOUND DRESSING MATERIALS; WOUND DRESSINGS;

CHITOSAN;

CARBON DIOXIDE; CHITOSAN; LYSOSTAPHIN; PROTEIN;

BACTERIUM; CARBON DIOXIDE; CHITIN; ENZYME ACTIVITY; INSECTICIDE; PROTEIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CHEMICAL STRUCTURE; IN VITRO STUDY; MASTITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; SKIN INFECTION; SOFT TISSUE INFECTION; SOLUBILIZATION; STAPHYLOCOCCUS AUREUS; WOUND CARE; WOUND DRESSING; WOUND INFECTION;

ANIMALIA; BOVINAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 84903329734     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.12568     Document Type: Article

References (36)

1. Belyansky, I., Tsirline, V.B., Martin, T.R., Klima, D.A., Heath, J., Lincourt, A.E., Satishkumar, R., Vertegel, A. et al. (2011) The addition of lysostaphin dramatically improves survival, protects porcine biomesh from infection, and improves graft tensile shear strength. J Surg Res 171, 409-415.
2. Busilacchi, A., Gigante, A., Mattioli-Belmonte, M., Manzotti, S. and Muzzarelli, R.A. (2013) Chitosan stabilizes platelet growth factors and modulates stem cell differentiation toward tissue regeneration. Carbohydr Polym 98, 665-676.
3. Climo, M.W., Patron, R.L., Goldstein, B.P. and Archer, G.L. (1998) Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis. Antimicrob Agents Chemother 42, 1355-1360.
4. Cui, F., Li, G., Huang, J., Zhang, J., Lu, M., Lu, W. and Huang, Q. (2010) Extension of nasal anti-Staphylococcus aureus efficacy of lysostaphin by its incorporation into a chitosan-o/w cream. Drug Deliv 17, 617-623.
5. Cui, F., Li, G., Huang, J., Zhang, J., Lu, M., Lu, W., Husan, J. and Huang, Q. (2011) Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with anti-methicillin-resistant Staphylococcus aureus and promotion wound healing properties. Drug Deliv 18, 173-180.
6. Dajcs, J.J., Hume, E.B.H., Moreau, J.M., Caballero, A.R., Cannon, B.M. and O'Callaghan, R.J. (2000) Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Invest Ophthalmol Vis Sci 41, 1432-1437.
7. Desbois, A.P., Gemmell, C.G. and Coote, P.J. (2010) In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic methicillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents 35, 559-565.
8. Fry, D.E. (2013) The continued challenge of Staphylococcus aureus in the surgical patient. Am Surg 79, 1-10.
9. 2 solutions. Carbohydr Polym 102, 901-911.
10. Goyal, N., Miller, A., Tripathi, M. and Parvizi, J. (2013) Methicillin-resistant Staphylococcus aureus (MRSA): colonisation and pre-operative screening. Bone Joint J 95, 4-9.
11. Iversen, O. and Grov, A. (1973) Studies on lysostaphin. Separation and characterization of three enzymes. Eur J Biochem 38, 293-300.
12. Jayakumar, R., Prabaharan, M., Sudheesh Kumar, P.T., Nair, S.V. and Tamura, H. (2011) Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnol Adv 29, 322-337.
13. Kolodziejska, I., Skierka, E., Sadowska, M., Kolodziejski, W. and Niecikowska, C. (2008) Effect of extracting time and temperature on yield of gelatin from different fish offal. Food Chem 107, 700-706.
14. Lavrence, J.C. (1994) Dressings and wound infections. Am J Surg 167, 21S-24S.
15. Lin, Y.C., Tan, F.J., Marra, K.G., Jan, S.S. and Liu, D.C. (2009) Synthesis and characterization of collagen/hyaluronan/chitosan composite sponges for potential biomedical applications. Acta Biomater 5, 2591-2600.
16. Ma, P.X. (2008) Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 60, 184-198.
17. Marova, I. and Kovar, J. (1993) Spectrophotometric detection of bacteriolytic activity of diluted lysostaphin solutions. Folia Microbiol 38, 153-158.
18. Miao, J., Pangule, R.C., Paskaleva, E.E., Hwang, E.E., Kane, R.S., Linhardt, R.J. and Dordick, J.S. (2011) Lysostaphin-functionalized cellulose fibers with antistaphylococcal activity for wound healing applications. Biomaterials 32, 9557-9567.
19. Mierau, I., Leij, P., Van Swam, I., Blommestein, B., Floris, E., Mond, J. and Smidt, E.J. (2005) Industrial-scale production and purification of a heterologous protein in Lactococcus lactis using the nisin-controlled gene expression system NICE: the case of lysostaphin. Microb Cell Fact 4, 15.
20. Miller, J.M., Creazzo, J. and Witt, C. (1992) Wound healing: an introductory clinical approach. Contemp Pediatr Physician 1, 38-42.
21. Nandagiri, V.K., Gentile, P., Chiono, V., Tonda-Turo, C., Matsiko, A., Ramtoola, Z., Montevecchi, F.M. and Ciardelli, G. (2011) Incorporation of PLGA nanoparticles into porous chitosan-gelatin scaffolds: influence on the physical properties and cell behavior. J Mech Behav Biomed Mater 4, 1318-1327.
22. Park, P.W., Senior, R.M., Griffin, G.L., Broekelmann, T.J., Mudd, M.S. and Mecham, R.P. (1995) Binding and degradation of elastin by the staphylolytic enzyme lysostaphin. Int J Biochem Cell Biol 27, 139-146.
23. Sarem, M., Moztarzadeh, F. and Mozafari, M. (2013) How can genipin assist gelatin/carbohydrate chitosan scaffolds to act as replacements of load-bearing soft tissues? Carbohydr Polym 93, 635-643.
24. Schindler, C.A. and Schuhardt, V.T. (1964) Lysostaphin: a new bacteriolytic agent for the Staphylococcus. Proc Natl Acad Sci USA 51, 414-421.
25. Schleifer, K.H. and Kandler, O. (1972) Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36, 407-477.
26. Sen, C.K., Gordillo, G.M., Roy, S., Kirsner, R., Lambert, L., Hunt, T.K., Gottrup, F., Gurtner, G.C. et al. (2009) Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 17, 763-771.
27. Sjolund, M. and Kahlmeter, G. (2008) Staphylococci in primary skin and soft tissue infections in a Swedish county. Scand J Infect Dis 40, 894-898.
28. Szweda, P., Lacka, I., Kotlowski, R. and Synowiecki, J. (2007) Protective effect of lysostaphin from Staphylococcus simulans against Staphylococcus aureus in milk and some other food products. J Food Saf 27, 265-274.
29. Szweda, P., Schielmann, M., Kotlowski, R., Gorczyca, G., Zalewska, M. and Milewski, S. (2012) Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus. Appl Microbiol Biotechnol 96, 1157-1174.
30. Szweda, P., Gorczyca, G., Filipkowski, P., Zalewska, M. and Milewski, S. (2014a) Efficient production of Staphylococcus simulans lysostaphin in a benchtop bioreactor by a recombinant E. coli. Prep Biochem Biotechnol 44, 370-381.
31. Szweda, P., Scheillman, M., Frankowska, A., Kot, B. and Zalewska, M. (2014b) Lysostaphin, nisin and polymyxin B as effective agents against antibiotic resistant Staphylococcus aureus strains isolated from cows with mastitis in the eastern Poland. J Vet Med Sci 76, 355-362.
32. Walencka, E., Sadowska, B., Rozalska, S., Hryniewicz, W. and Rozalska, B. (2005) Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication. Pol J Microbiol 54, 191-200.
33. Walencka, E., Sadowska, B., Rozalska, S., Hryniewicz, W. and Rozalska, B. (2006) Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin. Folia Microbiol 51, 381-386.
34. Wu, J.A., Kusuma, C., Mond, J.J. and Kokai-Kun, J.F. (2003) Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 47, 3407-3414.
35. Yan, L.P., Wang, Y.J., Ren, L., Wu, G., Caridade, S.G., Fan, J.B., Wang, L.Y., Ji, P.H. et al. (2010) Genipin-cross-linked collagen/chitosan biomimetic scaffolds for articular cartilage tissue engineering applications. J Biomed Mater Res A 95, 465-475.
36. Zhao, H., Blazanovic, K., Choi, Y., Bailey-Kellogg, C. and Griswold, K.E. (2014) Gene and protein sequence optimization for high level production of fully active and a glycosylated lysostaphin in Pichia pastoris. Appl Environ Microbiol. 80, 2746-2753.